National Drug Abuse Treatment 

 DELAWARE VALLEY NODE


DELAWARE VALLEY NODE

George E. Woody, M.D.
Principal Investigator

Professor
Department of Psychiatry
University of Pennsylvania
Treatment Research Institute
600 Public Ledger Bldg.
150 S. Independence Mall - West
Philadelphia, PA 19106-3475
woody@tresearch.org
http://www.med.upenn.edu/csa/trials_network.html (Node)
http://www.tresearch.org/ctn/ctn.htm (Node)
http://www.nida.nih.gov/CTN/centers/Delaware.html (NIDA)

The Delaware Valley Node joined the Clinical Trials Network in September 1999. This Node is part of the Center for Studies of Addiction at the University of Pennsylvania and the Treatment Research Institute in Philadelphia (the Regional Research and Training Center (RRTC)); and is also affiliated with Thomas Jefferson University School of Medicine and the University of Medicine and Dentistry of New Jersey. There are 15 CTPs in its provider network; serving residents of New Jersey, Pennsylvania and Delaware; in addition, the DV Node includes one managed behavioral health care organization with over 500,000 Philadelphia area members. The DV Node member organizations provide services to patients with every type of substance use disorder including special populations such as: 1) persons living with HIV, 2) adolescents, 3) veterans, 4) women with children, and 5) patients living in rural areas.


FIND IT!  Publications with Delaware Valley involvement


DELAWARE VALLEY NODE PROTOCOL INVOLVEMENT

  Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults

Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment

Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment

Starting Treatment with Agonist Replacement Therapies (START)

Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2008 -- http://ctndisseminationlibrary.org/nodes/dvnode.htm
info@ctndisseminationlibrary.org